A nurse administers a malaria vaccine to an infant at the Lumumba Sub-County hospital in Kisumu, Kenya, July 1, 2022. [VOA] The World Health Organization on Monday announced the recommendation of ...

Data from the second cohort showed the vaccine to be 45.0% effective in extending time to first infection (95% CI, 31.4 - 55.9; P < .0001).

A recently approved drug for malaria treatment offers hope to millions of children who suffer from the disease in Africa.

The Indian Council of Medical Research (ICMR) has called upon domestic vaccine manufacturers to collaborate in launching and ...

A monoclonal antibody (mAb), L9LS, shows promise in preventing malaria infection, according to the results of a small, proof-of-concept study reported in The New England Journal of Medicine. Of 17 ...

Vaccine availability People who initially received a subcutaneous first dose of Jynneos can get an intradermal second dose, or they can get both doses using the intradermal method. According to the ...